9 December 2025 - Top Stories

Recent developments in Australian health and healthtech reflect a landscape of evolving opportunities and ongoing challenges. Notably, veterinary use of CBD in dogs is gaining acceptance, with data indicating that around 7.3% of dogs in the US have been given hemp or CBD products, especially older dogs or those with health issues. This trend suggests a potential shift in pet healthcare management, possibly influencing similar approaches in Australia.

Meanwhile, the Department of Veterans Affairs is planning to reform its medical report fee structure to better align with actual costs and curb high charges, which have reached up to $30,000 in some cases. This move aims to improve fairness and compliance, potentially impacting veteran access to affordable assessments.

In infectious disease, pertussis cases surged in Australia in 2024, with over 23,970 cases reported—up from 2,452 in 2023. The rise is linked to waning immunity and reduced natural exposure, highlighting the importance of sustained vaccination efforts and improved vaccine formulations to control long-term spread.

On the screening front, a study on breast density notifications revealed increased anxiety among women without clear benefits. While women felt more inclined to discuss results with GPs, the findings underscore the need for balanced communication strategies to avoid unnecessary worry and costs.

In therapeutics, Eli Lilly is preparing to submit orforglipron, an oral GLP-1 receptor agonist, for Australian approval. Clinical trials show promising weight loss and HbA1c reductions, potentially offering a new oral treatment option for obesity and type 2 diabetes management in Australia.

• CBD use in pets is increasing, especially for older or health-compromised dogs.
• DVA plans to reform medical report fees to improve fairness and compliance.
• Pertussis cases have surged, emphasising the need for ongoing vaccination efforts.
• Breast density notifications may cause more anxiety without clear benefits.
• Orforglipron shows promise as an oral weight and diabetes treatment.
• Australian health policy continues to adapt amid funding and workforce pressures.